Reaction
Viral Vasculitis reporting signals
As of the last recalculation, Viral Vasculitis appears in 106 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 204.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 11 | 204.8 | 205.0 |
| Polatuzumab Vedotin | 4 | 83.6 | 83.6 |